$EGAN

eGain Shares Drop 22.5% After Fiscal 2027 Outlook Points to Lower Revenue

eGain (NASDAQ: EGAN) shares dropped 22.5% to $5.51 in pre-market trading after reporting fiscal Q4 and full-year 2026 results. Revenue fell 4% YoY to $22.2M in Q4, while full-year revenue was $91.1M. AI customer revenue grew 20% to $55.1M. For fiscal 2027, eGain forecasts revenue of $84.5M-$86.0M, a 7% decline, and adjusted EBITDA of $0.7M-$1.4M.

Original reporting
Published Sep 5, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 5, 2026, 1:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
eGain Shares Drop 22.5% After Fiscal 2027 Outlook Points to Lower Revenue — source image
Decision brief

The 30-second read

$EGANBearishHigh
01

Why it matters

The new guidance signals a contraction in legacy revenue, raising concerns about near‑term profitability.

02

Market read

The earnings and guidance release is the primary catalyst for the stock's 22.5% pre‑market decline.

03

What to watch

Potential upside from Gartner recognition and expanding AI customer base.

Relevance 6/10Novelty 7/10Timing: pre‑market today

Background

eGain is a niche AI‑enabled customer service software provider with modest revenues.

Company-level read

Ticker impact

$EGANBearishHigh confidence
Context

eGain reported FY2026 results and issued FY2027 guidance forecasting revenue decline and lower adjusted EBITDA.

Expected impact

Further downside pressure in pre‑market and early session trading.

Evidence & confidence

Guidance is a primary disclosure that materially changes outlook; the stock already fell 22.5% on the news.

Market effects

AI‑focused SaaS segment may see heightened scrutiny on growth prospects.

Limited; primarily affects US micro‑cap investors.

Low; the company is small and not a market driver.

Counterpoint

If AI revenue growth sustains, the stock may be oversold after the sharp drop.

Key entities

  • Ashu Roy

    CEO of eGain who commented on FY2026 and AI growth.

Related articles

$EGANLow

EGAIN Corp FY 2026: Revenue $91.14M, EPS $0.32— 10-K Summary

EGAIN Corp reported FY 2026 revenue of $91.14M, up from $88.43M, but net income fell to $8.88M and EPS declined to $0.32. Growth was driven by higher demand and price realization, with a shift to direct-to-consumer channels. The company completed capacity expansions and projects continued growth and margin improvement.

$EGANMedAI 8/10

eGain (EGAN) Q4 2026 Earnings Call Transcript

eGain (EGAN) reported fiscal 2026 revenue of $91.1M, up 3% YoY, with AI customer revenue growing 20%. Adjusted EBITDA was $13.6M, a 15% margin. Q4 revenue was $22.2M, down from $23.2M YoY. The company guided Q1 2027 revenue to $20.9M-$21.4M and fiscal 2027 revenue to $84.5M-$86.0M, with AI revenue growth expected at 8%-10%. Management targets $100M-$120M in AI ARR by 2030. Share repurchases totaled $11.5M for the year.

$EGANHigh

Why is eGain stock plunging over 20% today?

eGain (EGAN) stock fell 22.5% to $5.51 after reporting Q4 and FY2026 earnings. While AI revenue grew 20% to $55.1M, total Q4 revenue declined 4% to $22.2M. FY2027 guidance projects 7% lower revenue and a GAAP net loss, despite recognition in Gartner's Magic Quadrant. The S&P 500, Dow Jones, and Nasdaq showed minimal movement, indicating the drop was company-specific.

$EGANMed

EGAIN Corp (EGAN): Results of Operations and Financial Condition

EGAIN Corp (EGAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ eGain Reports Fiscal 2026 Results: Total Revenue Up 3%, AI Customer Revenue Up 20%, Company Named a Leader in Gartner's First Customer Service Knowledge Management MQ ​ Sunnyvale, CA (September 3, 2026) – eGain (Nasdaq: EGAN), a leading provider of AI-powered knowl

$BCPCMedAI 8/10

Balchem Corp (BCPC) Q3 2026 Earnings Call Highlights: Record Revenue, 29th Straight

Balchem Corp (BCPC) reported Q3 2026 record revenue of $291M, up 8.6%, with all segments growing. EBITDA rose 12.4% to $80M, marking 29 straight quarters of growth. The company faces inflationary pressures and seasonality challenges but expects year-over-year growth in Q4. Inventory increased to $177M due to inflation and growth. Clinical trials in Alzheimer's and cardiovascular health show promise, with marketing efforts planned. BCPC's effective tax rate is expected to be 22.5-23%.